Short- and long-term natural history of three neurodegenerative biomarkers among middle-aged and older adults
Journal of Neuromuscular Diseases · 2025
DOI: 10.1177/22143602241301636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuromuscular Diseases, 2025. Verfasst von Rikuta Hamaya und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Glial Fibrillary Acidic Protein, Neurofilament Proteins, tau Proteins, Neurodegenerative Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Little is known about the longitudinal trajectories of novel neurodegenerative biomarkers including neurofilament light (NfL), tau, and glial fibrillary acidic protein (GFAP).
Objectives
We aimed to investigate the short- and long-term natural history of these biomarkers measured longitudinally among healthy adults.
Methods
In this cohort study from the Physicians’ Health Study (PHS), VITamin D and OmegA-3 TriaL (VITAL), and COcoa Supplement and Multivitamin Outcomes Study (COSMOS), we included 1299 adults with bloods collected 2 years (VITAL and COSMOS) or 14 years (PHS) apart and without diagnosed neurodegenerative diseases before baseline or during follow-up through two years after the final blood collection. Associations between baseline characteristics and changes in NfL, tau, and GFAP were evaluated.
Results
Mean (SD) age at baseline was 49.8 (6.8), 67.5 (6.2), and 70.3 (5.7) in PHS, VITAL, and COSMOS, respectively. PHS enrolled only men while ∼50% of the VITAL and COSMOS populations in this study were men. Median percent changes (IQR) of NfL were 40.6% (2.4, 58.2) increase over 14 years (PHS) and 8.5% (−6.6, 28.6) over 2 years (VITAL and COSMOS); increases in tau were 101% (10.7, 285) over 14 years and 11.8% (−35.2, 106) over 2 years; and increases in GFAP were 25.1% (−1.7, 23.8) over 14 years and 5.6% (−12.8, 28.6) over 2 years. In multivariable models, age was most strongly and robustly associated with 14-year changes in NfL and GFAP (adjusted p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
- Biogen, Cambridge, MA, USA.
- Division of Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
- Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, USA.
Zitieren
APA
Hamaya, R., Rist, P. M., Kupelian, V., Gotter, A. L., Sohn, J., Rubel, C. E., Gaziano, J. M., Manson, J. E., & Sesso, H. D. (2025). Short- and long-term natural history of three neurodegenerative biomarkers among middle-aged and older adults. Journal of Neuromuscular Diseases. https://doi.org/10.1177/22143602241301636
Vancouver
Hamaya R, Rist PM, Kupelian V, Gotter AL, Sohn J, Rubel CE, et al. Short- and long-term natural history of three neurodegenerative biomarkers among middle-aged and older adults. Journal of Neuromuscular Diseases. 2025. doi:10.1177/22143602241301636
BibTeX
@article{Hamaya2025,
author = {Hamaya, Rikuta and Rist, Pamela M and Kupelian, Varant and Gotter, Anthony L and Sohn, Jihee and Rubel, Carrie E and Gaziano, J Michael and Manson, JoAnn E and Sesso, Howard D},
title = {Short- and long-term natural history of three neurodegenerative biomarkers among middle-aged and older adults},
journal = {Journal of Neuromuscular Diseases},
year = {2025},
doi = {10.1177/22143602241301636}
}
EUVIMED